Bogart Wealth LLC boosted its holdings in Danaher Co. (NYSE:DHR – Free Report) by 11.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,548 shares of the conglomerate’s stock after purchasing an additional 3,783 shares during the quarter. Bogart Wealth LLC’s holdings in Danaher were worth $8,619,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. AMF Tjanstepension AB bought a new stake in shares of Danaher in the third quarter worth about $5,923,000. Wedge Capital Management L L P NC increased its stake in Danaher by 3.2% in the 3rd quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 38 shares during the last quarter. CX Institutional raised its holdings in shares of Danaher by 5.5% during the 3rd quarter. CX Institutional now owns 2,908 shares of the conglomerate’s stock worth $808,000 after acquiring an additional 151 shares in the last quarter. Creative Planning boosted its position in shares of Danaher by 3.1% during the 3rd quarter. Creative Planning now owns 126,340 shares of the conglomerate’s stock valued at $35,125,000 after acquiring an additional 3,749 shares during the last quarter. Finally, Magnus Financial Group LLC purchased a new position in shares of Danaher in the third quarter valued at $233,000. 79.05% of the stock is currently owned by institutional investors.
Insider Activity
In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 11.10% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Stock Report on DHR
Danaher Stock Up 0.7 %
Danaher stock opened at $203.56 on Friday. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The business has a fifty day moving average price of $230.49 and a 200-day moving average price of $250.28. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market capitalization of $147.03 billion, a price-to-earnings ratio of 38.55, a PEG ratio of 2.68 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the business earned $2.09 EPS. Equities research analysts forecast that Danaher Co. will post 7.67 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.45%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Most active stocks: Dollar volume vs share volume
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Market Cap Calculator: How to Calculate Market Cap
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.